ProLung Installs Chief Accounting Officer

  • 11 May 2017

Salt Lake City, UT, May 11, 2017 — ProLung, Inc., the leader in innovative predictive analytics technology and non-invasive tests for lung cancer, announced today the promotion of Aaron Stout to Chief Accounting Officer. […]

Shareholder Update Letter

  • 15 January 2017

January 15, 2017

 

Happy New Year from ProLung!

2016 has been a spectacular year.

To achieve our research goals more rapidly, we assembled the most extensive team of clinical investigators of lung cancer in pulmonology.

This speeds the […]

Gregory C. Simon Meeting

  • 10 December 2016

Steven C. Eror, President and CEO, meets with Gregory C. Simon, White House Cancer Moonshot Task Force, Executive Director in the Office of the Vice President.

ProLung Interviewed by National Healthcare Reporter

  • 2 November 2016

 

12/10/2016

   ProLungDX seeks funds for cancer test; sees eventual IPO – CEO 
   Proprietary Intelligence

Story

ProLungDX, a maker of lung cancer detection devices, is looking to raise USD 5.25m from high net worth investors for US […]

University of Liverpool Lung Cancer Research

  • 3 June 2016

Lung cancer survival rate increases by 73% if caught early
A major lung cancer screening trial, conducted by experts at the University of Liverpool, has found
that patients with a high risk of
developing lung cancer can be identified
with early stage disease […]

ProLungdx Announces Todd Morgan as Chairman of the Board

  • 19 May 2016

Salt Lake City, Utah, May 19, 2016 – Fresh Medical Laboratories, Inc, doing business as ProLungdx™, announced today that its board has appointed Todd Morgan as Chairman of the Board of Directors.  Mr. Morgan […]

ProLung study presented at IASLC 2015 Conference

  • 22 September 2015

September 22, 2015, Salt Lake City, Utah – A study comparing results from the ProLung EPN scan to the results of PET scans was presented at the 16th World Conference on Lung Cancer in Denver, […]

Dr. Jeffrey S. O’Driscoll joins Board of Directors

  • 21 August 2015

August 20, 2015, Salt Lake City Utah – The Board of Directors of the Company appointed Jeffrey S. O’Driscoll as a director of the Company.  Dr. O’Driscoll has practiced as an emergency physician since 1992.  He started […]

Leavitt Partners CEO McKeown joins ProLung Board of Directors

  • 2 July 2014

Salt Lake City, Utah (July 2, 2014) – “Rich McKeown brings a deep understanding of the healthcare industry as the chief executive of one of the nation’s most respected healthcare consulting firms,” said ProLung President […]

ProLung names Clark Campbell as Chairman of the Board

  • 12 September 2012

September 11, 2012, Salt Lake City, Utah—The medical technology company, ProLung, today announced the naming current board member Clark A. Campbell, Ph.D. as its new Chairman, replacing William A. Fresh, who continues as a Director. Campbell steps into this role as the company makes preparations to market the ProLung Test, a new tool in the early detection of lung cancer. Studies have shown that the test immediately and accurately identifies malignancy in patients who have been found to have an indeterminate lung mass. This can help solve the crucial problem of late detection, a major factor in lung cancer’s high mortality rate. “Dr. Campbell’s project management expertise will be invaluable as we embark on the final stages of preparing the ProLung Test for U.S. and international markets,” said Steven C. Eror, president and CEO of ProLung. “We’re fortunate to have him join us in our efforts to help give lung cancer patients a better chance for survival.”